Observational study on breast cancer using transcriptomic and immune analysis
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
This study looks at the genetic and immune features of breast cancer in patients aged 25 to 80 to better understand how the disease behaves.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 25 Years to 80 Years |
| Sex | Female |
| Sponsor | Irccs Synlab Sdn Academic / other |
| Locations | 1 site (Naples) |
| Trial ID | NCT05809128 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize the onco-immunologic profile of breast cancer patients through the analysis of altered transcriptomic data and bioimaging of neoplastic tissue. It involves surgical intervention for breast cancer followed by imaging tests to evaluate the extracted markers. The study will include patients aged 25 to 80 who have been clinically diagnosed with breast cancer, allowing for a comprehensive understanding of the disease's biological behavior.
Who should consider this trial
Good fit: Ideal candidates for this study are breast cancer patients aged 25 to 80 years.
Not a fit: Patients who refuse to participate or do not meet the age criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for breast cancer patients.
How similar studies have performed: While similar approaches have been explored, this specific combination of transcriptomic and immune analysis in breast cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of breast cancer. * patients 25 to 80 years of age Exclusion Criteria: * Patients who refuse to participate in the study; * Patients who do not fall within the age range mentioned above
Where this trial is running
Naples
- IRCCS Synlab SDN — Naples, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.